Mobile applications for self-management of diabetes

Study design and presentation made it difficult to distinguish the effect of the app and the effect of additional interactions with study personnel or health care providers. Of the eight apps available for usability testing, three apps (two for type 1 and one for type 2 diabetes) were scored by rese...

Full description

Bibliographic Details
Main Author: Veazie, Stephanie
Corporate Authors: United States Agency for Healthcare Research and Quality, Effective Health Care Program (U.S.), Scientific Resource Center (Portland, Or.)
Format: eBook
Language:English
Published: Rockville, MD Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services 2018, May 2018
Series:Technical brief
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 03941nam a2200277 u 4500
001 EB002220345
003 EBX01000000000000001357306
005 00000000000000.0
007 tu|||||||||||||||||||||
008 240703 r ||| eng
100 1 |a Veazie, Stephanie 
245 0 0 |a Mobile applications for self-management of diabetes  |h Elektronische Ressource  |c investigators, Stephanie Veazie, Kara Winchell, Jennifer Gilbert, Robin Paynter, Ilya Ivlev, Karen Eden, Kerri Nussbaum, Nicole Weiskopf, Jeanne-Marie Guise, Mark Helfand 
260 |a Rockville, MD  |b Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services  |c 2018, May 2018 
300 |a 1 PDF file (various pagings)  |b illustrations 
505 0 |a Includes bibliographical references 
710 2 |a United States  |b Agency for Healthcare Research and Quality 
710 2 |a Effective Health Care Program (U.S.) 
710 2 |a Scientific Resource Center (Portland, Or.) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Technical brief 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK518944  |3 Volltext 
082 0 |a 610 
520 |a Study design and presentation made it difficult to distinguish the effect of the app and the effect of additional interactions with study personnel or health care providers. Of the eight apps available for usability testing, three apps (two for type 1 and one for type 2 diabetes) were scored by researchers as "acceptable," two apps (type 1 diabetes) as "marginal," and three apps (one for type 1 and two for type 2 diabetes) as "not acceptable." IMPLICATIONS: Some apps for diabetes self-management may improve outcomes in the short-term, but the effect cannot be distinguished from the concomitant effect of additional support from a health care provider. More rigorous and longer-term evaluations are needed to determine how these apps affect weight, blood pressure, quality of life, and complications of diabetes 
520 |a BACKGROUND: While hundreds of mobile applications (apps) for diabetes self-management are commercially available, patients lack information on which apps are effective in improving diabetes-related outcomes. PURPOSE: Examine the evidence, usability, and features of commercially available mobile apps for self-management of type 1 and type 2 diabetes. METHODS: We searched Ovid/Medline and the Cochrane Database of Systematic Reviews for systematic reviews and technology assessments, and selected five recent, high-quality systematic reviews of highest relevance. We also conducted searches online and through Ovid/Medline, CINAHL, Embase, and ClinicalTrials.gov to identify additional, recently published primary studies. We used predetermined criteria to identify eligible studies, then extracted study-level data. We conducted quality assessments, extracted technical specifications and costs, and evaluated the usability of each app.  
520 |a FINDINGS: We identified 15 studies/analyses evaluating 11 unique apps: six apps for type 1 diabetes and five for type 2 diabetes. Two apps had multiple tiers of access (free and paid), which resulted in the evaluation of features of 13 apps. Common features of apps include the ability to track blood glucose, HbA1c, medications, physical activity, and weight. Studies were 2-12 months long. For type 1 diabetes, patients had clinically significant improvement in HbA1c if they used either of two apps and statistically significant improvement using one additional app. For type 2 diabetes, patients using any of three apps experienced clinical and statistical improvement in HbA1c. Patients using two apps for type 1 diabetes experienced improvements in hypoglycemic episodes. Patients did not experience improvements in quality of life, blood pressure, weight, or body mass index outcomes, regardless of the app or type of diabetes. The quality of studies was variable.